Last updated: August 30, 2026

Application No. 18/443,878

METHODS OF TREATING MULTIPLE MYELOMA

Non-Final OA

Filed

Feb 16, 2024

Priority

Jan 28, 2019 — provisional 62/797,876 +7 more

Examiner

SANG, HONG

Art Unit

Tech Center

Assignee

Sanofi S.A.

OA Round

1 (Non-Final)

This examiner grants 55% of cases after interview

— +62.4% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 927 resolved cases, 2023–2026

Examiner Intelligence

SANG, HONG View full profile →

Grants 55% of resolved cases

Career Allowance Rate

508 granted / 927 resolved

-5.2% vs TC avg

Strong +62% interview lift

Without

With

+62.4%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

44 currently pending

Career history

967

Total Applications

across all art units

Statute-Specific Performance

§101

4.5%

-35.5% vs TC avg

§103

28.3%

-11.7% vs TC avg

§102

16.9%

-23.1% vs TC avg

§112

29.9%

-10.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 927 resolved cases

Prosecution Timeline

Feb 16, 2024

Application Filed

Aug 17, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/556,863

Patent 12714753

MEDITOPES AND MEDITOPE-BINDING ANTIBODIES AND USES THEREOF

4y 8m to grant Granted Aug 25, 2026

17/742,702

Patent 12715929

IMPROVED ANTAGONISTIC ANTI-HUMAN CD40 MONOCLONAL ANTIBODIES

4y 3m to grant Granted Aug 25, 2026

16/964,847

Patent 12708644

DENDRITIC CELL VACCINATION SEQUENTIAL TO CHEMOTHERAPY

6y 0m to grant Granted Aug 18, 2026

17/783,506

Patent 12674002

MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING

4y 1m to grant Granted Jul 07, 2026

19/064,618

Patent 12655391

MODIFIED K562 FEEDER CELL LINE EXPRESSING FACTORS THAT ENHANCE THE ACTIVATION AND PROLIFERATION OF NATURAL KILLER CELLS AND A METHOD FOR ITS PRODUCTION

1y 3m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

55%

Grant Probability

99%

With Interview (+62.4%)

3y 5m (~11m remaining)

Median Time to Grant

Low

PTA Risk

Based on 927 resolved cases by this examiner. Grant probability derived from career allowance rate.